Active Ingredient History
T cells are one of the important types of white blood cells of the immune system and play a central role in the adaptive immune response. T cells can be distinguished from other lymphocytes by the presence of a T-cell receptor (TCR) on their cell surface. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 2)
Anemia, Refractory (Phase 2)
Antigens, CD19 (Phase 1)
Bone Marrow Cells (Phase 1)
Brain Neoplasms (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Colorectal Neoplasms (Phase 1)
Cytomegalovirus Infections (Phase 1/Phase 2)
Esophageal Neoplasms (Phase 1)
Fanconi Anemia (Phase 1)
Glioblastoma (Phase 1/Phase 2)
Glioma (Phase 1/Phase 2)
Gliosarcoma (Phase 1/Phase 2)
Graft vs Host Disease (Phase 2)
Head and Neck Neoplasms (Phase 1)
Hematologic Neoplasms (Phase 1/Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 1)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 2)
Kidney Failure, Chronic (Phase 1)
Leukemia (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasm, Residual (Phase 1)
Neoplasms (Phase 2)
Organ Transplantation (Phase 1)
Pancreatic Neoplasms (Phase 1)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Renal Insufficiency, Chronic (Phase 1)
Sezary Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 1)
Thrombocytopenia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
